Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anticoagulation Combined With Tocilizumab for Interleukin-6 Receptor Inhibition in Acute Cerebral Venous Thrombosis

NCT07801638 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT07801638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07801638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anticoagulation Combined With Tocilizumab for Interleukin-6 Receptor Inhibition in Acute Cerebral Venous Thrombosis
Lead sponsor
Capital Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2025
Completion date
September 30, 2028
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral venous thrombosis